Ellen M. Brady
Analyst-Equity at LifeTech Research, Inc.
Profile
Dr. Ellen M.
Brady, MD, is Vice President of Clinical & Regulatory Research at LifeTech Research, Inc.
Dr. Brady joined LifeTech Research in 2004.
Prior to LifeTech, she spent 20 years within the pharmaceutical industry, working for both major (Sandoz, Ciba-Geigy, Janssen Pharmaceuticals and Serono) and development-stage companies (NPS Pharmaceuticals and Esperion Therapeutics).
Most recently, she was Senior Director, Clinical Research at Esperion prior to its acquisition by Pfizer.
Throughout her career, she has been responsible for the clinical development of products indicated for use in cardiology, neurology, gastroenterology, endocrinology/metabolism, HIV/AIDS and asthma.
Her responsibilities included strategic planning around clinical development, regulatory and market issues as well as the actual design and execution of clinical trial programs.
Products ranged from pre-IND to phase IV stages of development.
she is a board certified general internist with a master's degree in public health from the Johns Hopkins School of Hygiene and Public Health.
Her early career in academia focused on issues related to healthcare delivery, international health and public policy.
Currently, she has an adjunct professorship within the University of Utah College of Pharmacy.
Ellen M. Brady active positions
| Companies | Position | Start |
|---|---|---|
LifeTech Research, Inc.
 LifeTech Research, Inc. Investment Banks/BrokersFinance Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling. | Analyst-Equity | 2003-12-31 |
Former positions of Ellen M. Brady
| Companies | Position | End |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| Serono Ltd. | Corporate Officer/Principal | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - |
| Ciba-Geigy Pharmaceuticals | Corporate Officer/Principal | - |
Training of Ellen M. Brady
| The Johns Hopkins University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
| Sandoz Pharmaceuticals Corp. | |
LifeTech Research, Inc.
LifeTech Research, Inc. Investment Banks/BrokersFinance Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling. | Finance |
| Serono Ltd. | |
| Ciba-Geigy Pharmaceuticals |
- Stock Market
- Insiders
- Ellen M. Brady
